In a recent case control study, dense patterns were observed to be associated with a higher relative risk estimate for the more aggressive grade 3 tumors than for grade 1 or 2 tumors.
The primary GBM culture BT116 was from an aggressive, grade IV GBM that was fatal in less than two years.
The reconstruction of large bone defects and restoration of joint function resulting from resection of aggressive grade III GCT around knee remains a challenging problem.
According to the WHO classification glial tumors of astrocytic origin are of four grades, ranging from the least aggressive grade I (pilocytic astrocytomas) to the grade II (low grade diffuse astrocytoma (DA)), the grade III (anaplastic astrocytoma (AA)) and the most aggressive grade IV (GBM).
There was also a trend for low HYAL2 expression in the most aggressive, grade 3 tumors, a result resembling that in diffuse large B-cell lymphomas (DLBCLs) [ 23].
The subgroup of "ductal-associated" tumors overlapped this dual (biphasic) component and had a less aggressive (grade I) HRs + phenotype, suggesting a more stable ductal-differentiation.
Similarly, the highest proportion of grade 3 tumours were found within the ALT group and the majority of Tel+ tumours were grade 2, while those that were ALT−/Tel− were mostly of the least aggressive grade 1.
Though the most aggressive grade IV GBM tumors are near-universally lethal, individual patient response to treatment is quite varied, making the decision to undergo high-dose chemotherapy over low-dose chemotherapy a difficult one [ 21].
Mammography still has a place in both arms, since DCIS is generally easier to detect with mammography [ 8, 10, 31- 33], although in one study MRI was found to detect more aggressive grade III DCIS than mammography [ 34].
In contrast, the highly aggressive (grade III) T24 cells were characterized by a prominent efficiency in motility, being able to successfully "heal the wound" in an incubation period of 24 hours, creating a compact monolayer of cells.
